{"count":18,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec/","filing_uuid":"02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/02b178e2-9dcb-46fa-a2a7-41bc8ff2a9ec/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig Monson","dt_posted":"2026-04-17T14:07:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":175642,"url":"https://lda.gov/api/v1/clients/175642/","client_id":1006245,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","general_description":"A coalition of organizations working on market-based solutions to drug pricing.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-07-12"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act S. 1032/H.R. 1843 - Increasing Transparency in Generic Drug Applications Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/s. 1533 - the Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/72311c6b-8b57-4315-8da8-b467e3968cfa/","filing_uuid":"72311c6b-8b57-4315-8da8-b467e3968cfa","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/72311c6b-8b57-4315-8da8-b467e3968cfa/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tavarski Hughes","dt_posted":"2026-04-17T16:35:22-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"240 Madison Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"MEMPHIS","registrant_state":"TN","registrant_zip":"38103","registrant":{"id":6440,"url":"https://lda.gov/api/v1/registrants/6440/","house_registrant_id":33435,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","description":null,"address_1":"240 Madison Avenue","address_2":null,"address_3":null,"address_4":null,"city":"MEMPHIS","state":"TN","state_display":"Tennessee","zip":"38103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAVARSKI HUGHES","contact_telephone":"+1 901-417-2486","dt_updated":"2026-07-18T18:34:35.847553-04:00"},"client":{"id":108763,"url":"https://lda.gov/api/v1/clients/108763/","client_id":12,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmacy Benefit Managers; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Federal Budget Process; Hospital Billing/Consolidation; Maternal Health; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Health Savings Accounts S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1418a58b-0775-4e45-9b77-06e8109c2656/","filing_uuid":"1418a58b-0775-4e45-9b77-06e8109c2656","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1418a58b-0775-4e45-9b77-06e8109c2656/print/","filing_document_content_type":"text/html","income":null,"expenses":"12210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-04-20T13:06:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law No. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law No. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law No. 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No. 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Biopharmaceutical innovation policy issues SECURE Rx Act of 2026 (draft) User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/","filing_uuid":"2a724a0a-e0ad-4918-ac11-b31bc71cfd7c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2a724a0a-e0ad-4918-ac11-b31bc71cfd7c/print/","filing_document_content_type":"text/html","income":null,"expenses":"299699.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-20T13:11:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c5d0123-1385-41b5-aa02-7303db5efcbf/","filing_uuid":"2c5d0123-1385-41b5-aa02-7303db5efcbf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c5d0123-1385-41b5-aa02-7303db5efcbf/print/","filing_document_content_type":"text/html","income":null,"expenses":"1640000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-04-20T21:36:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (P.L. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75), Provisions related to the pharmaceutical industry. Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1ffec1b7-a7af-4b72-b683-9783c231beb4/","filing_uuid":"1ffec1b7-a7af-4b72-b683-9783c231beb4","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1ffec1b7-a7af-4b72-b683-9783c231beb4/print/","filing_document_content_type":"text/html","income":null,"expenses":"2996995.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-04-21T12:15:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 3164; Ensuring Community Access to Pharmacist Service Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":"Republican Staff Director, House Oversight and Government Reform Committee","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/fe761c58-0637-4199-9062-747a124fa71a/","filing_uuid":"fe761c58-0637-4199-9062-747a124fa71a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/fe761c58-0637-4199-9062-747a124fa71a/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tavarski Hughes","dt_posted":"2026-07-18T18:16:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"240 Madison Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"MEMPHIS","registrant_state":"TN","registrant_zip":"38103","registrant":{"id":6440,"url":"https://lda.gov/api/v1/registrants/6440/","house_registrant_id":33435,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","description":null,"address_1":"240 Madison Avenue","address_2":null,"address_3":null,"address_4":null,"city":"MEMPHIS","state":"TN","state_display":"Tennessee","zip":"38103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAVARSKI HUGHES","contact_telephone":"+1 901-417-2486","dt_updated":"2026-07-18T18:34:35.847553-04:00"},"client":{"id":108763,"url":"https://lda.gov/api/v1/clients/108763/","client_id":12,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Federal Budget Process; Hospital Billing/Consolidation; Maternal Health; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Health Savings Accounts; Suprise Billing; Artificial Intelligence S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes. H.R. 8684 - Transparency in Billing Act of 2026 To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 9393 - Lower Costs, More Transparency Act of 2026 To promote price transparency in the health care sector","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform; Program Fraud Waste and Abuse S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington H.R. 93932 - Medicare Advantage Cost Transparency Act To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data. H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 To amend Title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. H.R. 8871 - DME Scammer Prevention Act of 2026 To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies. S. 3762 - Prior Authorization Relief Act To amend part C of the title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"AHIP","url":"www.ahip.org","address_1":"601 Pennsylvania Avenue, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/7f892462-d586-4f79-a9fa-8025deea583d/","filing_uuid":"7f892462-d586-4f79-a9fa-8025deea583d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7f892462-d586-4f79-a9fa-8025deea583d/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Bill McCarthy","dt_posted":"2026-07-20T13:12:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 M Street, NW, Suite 800 S","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":401105458,"url":"https://lda.gov/api/v1/registrants/401105458/","house_registrant_id":null,"name":"FDD ACTION","description":"Issue advocacy on U.S. national security and foreign policy","address_1":"1800 M Street, NW, Suite 800 S","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MCCARTHY","contact_telephone":"+1 202-207-0190","dt_updated":"2026-07-17T14:19:22.246604-04:00"},"client":{"id":203727,"url":"https://lda.gov/api/v1/clients/203727/","client_id":12,"name":"FDD ACTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-10-01"},"lobbying_activities":[{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"H.R. 1422, Enhanced Iran Sanctions Act, all provisions. H.R. 1800, Solidify Iran Sanctions Act (SISA), all provisions. H.R. 2683, Remote Access Security Act, all provisions. H.R. 3447, Chip Security Act, all provisions. H.R. 425, Repealing Big Brother Overreach Act, all provisions. H.R. 4397, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. H.R. 4505, Export Controls Enforcement Act, all provisions. H.R. 4530, STOP Shells Act, all provisions. H.R. 4920, BIS IT Modernization Act, all provisions. H.R. 4930, Counterfeit Notification Act, all provisions. H.R. 5490, Dismantle Foreign Scam Syndicates Act, all provisions. H.R. 5853, ECRA Penalty Increase Act, all provisions. H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement (STRIDE) Act, all provisions. H.R. 6322, Stop Stealing Our Chips Act, all provisions. H.R. 6331, Addressing Dangerous Vulnerabilities in Exports and Research to Strategic Adversaries, Regimes, and Industrial Entities of Security Concern (ADVERSARIES) Act, all provisions. H.R. 6624, Biological Intellectual Property Protection Act of 2025, all provisions. H.R. 6875, AI OVERWATCH Act, all provisions. H.R. 6996, Full AI Stack Export Promotion Act, all provisions. H.R. 7003, BIS Strategic Talent Recruitment to Enhance National Guardrails for Technological Handling (STRENGTH) Act, all provisions. H.R. 7184, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. H.R. 7552, CBW Fentanyl Act, all provisions. H.R. 8036, Interagency Coordination in Export Controls Act, all provisions. H.R. 8106, Rosatom Energy Sanctions Compliance and Unified Enforcement (RESCUE) Act, all provisions. H.R. 8169, Export Control Enforcement and Enhancement Act, all provisions. H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. H.R. 8202, ECRA Statute of Limitations Extension, all provisions. H.R. 8283, Deterring American AI Model Theft Act of 2026, all provisions. H.R. 8284, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 1473, Stop Stealing our Chips Act, all provisions. S. 1490, Global Hunt for Offshore Smuggling and Trafficking (GHOST) Act of 2025, all provisions. S. 1705, Chip Security Act, all provisions. S. 1889, Solidify Iran Sanctions Act (SISA), all provisions. S. 2293, Muslim Brotherhood Terrorist Designation Act of 2025, all provisions. S. 2677, Counterfeit Notification Act, all provisions. S. 2904, Sanctioning Harbors and Dodgers of Western Sanctions (SHADOW) Fleets Act, all provisions. S. 3172, A bill to repeal certain Acts that impose sanctions upon Syria, all provisions. S. 3452, Biological Intellectual Property Protection Act of 2025, all provisions. S. 3519, Remote Access Security Act, all provisions. S. 4281, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act, all provisions. S. 4446, Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, all provisions. S. 4456, AI OVERWATCH Act, all provisions. S. 4723, Eliminate PRC Organized Crime Act, all provisions. S. 4835, Bureau of Industry and Security License Administration Enhancement Act, all provisions. S. 556, Enhanced Iran Sanctions Act of 2025, all provisions. S. 63, CBW Fentanyl Act, all provisions. Issues Related to American Economic Statecraft; Anti-Money Laundering and Combating the Financing of Terrorism; Captagon, Fentanyl, and International Narcotics Production and Trafficking; China-Related Tax and Investment Authorities; Chinese Access to U.S. Capital Markets and Advanced Technology; DIB Capacity Tax Incentives; Evaluating Sanctions, Export Controls, and AML Regulations, Regulatory Authorities, and Legislative Authorities; Expansion of CFIUS Authorities; Foreign Investment in Latin America; Hezbollah, Iran, and IRGC Funding Streams; Implementation and Oversight of the Corporate Transparency Act; Implementation and Oversight of the Countering Americas Adversaries Through Sanctions Act (CAATSA); Implementation and Oversight of the Foreign Extortion Prevention Act; Iranian Oil Sanctions Enforcement; Muslim Brotherhood Funding Streams; National Security-Related Foreign Investment Screening Processes for U.S. Allies; Tax-Exempt Status of Organizations with Ties to U.S. Adversaries; U.S. Adversaries Illicit Finance Activities; U.S. Adversaries Sanctions Evasion Schemes; U.S. Anti-Corruption Sanctions and Strategy; U.S. China Sanctions Policy; U.S. Cuba Sanctions Policy; U.S. Export Control Policy; U.S. Houthi Sanctions Policy; U.S. International Sovereign Debt Policy; U.S. Investment Screening and Security; U.S. Iran Sanctions Policy; U.S. Iraq Sanctions Policy; U.S. Muslim Brotherhood Sanctions Policy; U.S. Nicaragua Sanctions Policy; U.S. Oman Sanctions; U.S. Polisario Front Sanctions Policy; U.S. Russia Oil Waivers and Sanctions Policy; U.S. Sanctions Authorities, Implementation, Enforcement, Resourcing, and Policy; U.S. Syria Sanctions Policy; U.S. Terror Finance Policy; and U.S. Turkey Sanctions Policy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.Con.Res. 38, Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from unauthorized hostilities in the Islamic Republic of Iran, all provisions. H.Con.Res. 40, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran, all provisions. H.Con.Res. 75, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove the United States Armed Forces from hostilities against the Islamic Republic of Iran, all provisions. H.Con.Res. 84, Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from Lebanon, all provisions. H.Con.Res. 86, Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran, all provisions. H.J.Res. 176, 2026 Authorization for Use of Military Force Against Iran, all provisions. H.J.Res. 200, Providing for congressional disapproval of the proposed foreign military sale to Turkey of certain defense articles and services, all provisions. H.R. 2505, Block the Use of Transatlantic Technology in Iranian Made Drones Act, all provisions. H.R. 7126, Securing Essential and Critical U.S. Resources and Elements (SECURE) Minerals Act, all provisions. H.R. 7146, Providing Our Regional Companions Upgraded Protection in Nefarious Environments (PORCUPINE) Act, all provisions. H.R. 7178, U.S.-Israel Anti-Killer Drone Act, all provisions. H.R. 7273, NASA Reauthorization Act of 2026, all provisions. H.R. 7540, United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act of 2026, all provisions. H.R. 8019, U.S.-Greece Defense Cooperation Advancement Act, all provisions. H.R. 8069, Strategic Subsea Cables Act of 2026, all provisions. H.R. 8168, Major Non-NATO Ally Terror Threat Assessment Act, all provisions. H.R. 8177, Critical Undersea Infrastructure Resilience Initiative Act, all provisions. H.R. 8649, Expanding the Defense Industrial Base Sales Act, all provisions. H.R. 8665, Allied Defense Sales Act, all provisions. H.R. 8787, Servicemember Payment Data Privacy and Security Act, all provisions. H.R. 9232, Critical Infrastructure Airspace Defense Act, all provisions. H.R. 9256, Ending Child Soldiers in Africa Act, all provisions. H.R. 9322, Abraham Accords Defense Cooperation Act of 2026, all provisions. H.R. 9366, Eastern Frontier Defense Infrastructure Readiness Act, all provisions. H.R. 9451, Seized Assets for Battlefield Equipment and Readiness (SABER) Act, all provisions. H.R. 9495, Department of Defense Appropriations Act, 2027, (issues related to U.S.-Ukraine Security Cooperation). H.R. 9550, Strategic Unmanned Systems Partnership Act, all provisions. H.Res. 1246, Expressing the sense of the House of Representatives in support of the integration of Kosovo into the North Atlantic Treaty Organization, all provisions. H.Res. 564, Calling for the return of abducted Ukrainian children before finalizing any peace agreement to end the war against Ukraine, all provisions. S. 1744, Providing Our Regional Companions Upgraded Protection in Nefarious Environments (PORCUPINE) Act, all provisions. S. 1962, Secure Space Act of 2025, all provisions. S. 2222, Critical Undersea Infrastructure Resilience Initiative Act, all provisions. S. 3249, Strategic Subsea Cables Act of 2026, all provisions. S. 3404, Satellite Cybersecurity Act of 2025, all provisions. S. 3659, Securing Essential and Critical U.S. Resources and Elements (SECURE) Minerals Act, all provisions. S. 3855, United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act, all provisions. S. 4219, Abraham Accords Defense Cooperation Act of 2026, all provisions. S. 4380, Critical Infrastructure Airspace Defense Act, all provisions. S. 4443, Eastern Mediterranean Gateway Act, all provisions. S. 4544, Stop Fueling Cartel Violence Act, all provisions. S. 4711, Strategic Unmanned Systems Partnership Act, all provisions. S. 4826, Seized Assets for Battlefield Equipment and Readiness (SABER) Act, all provisions. S. 933, NASA Transition Authorization Act of 2025, all provisions. S.J.Res. 114, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 123, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 163, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 184, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.J.Res. 185, A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress, all provisions. S.Res. 236, A resolution calling for the return of abducted Ukrainian children before finalizing any peace agreement to end the war against Ukraine, all provisions. H.R. 8800, National Defense Authorization Act for Fiscal Year 2027, (issues related to Actions to Evaluate and Invest in Ukrainian Defense Technologies; Additional Support for NATO Air Defense Against UAS; AI Agent Discovery and Security Standards; Air Force Fighter Fleet Recapitalization; Amendment to the Atomic Energy Act of 1954; Amendments to the Anti-Boycott Act of 2018; American Security Robotics Act; American-Hellenic-Israeli Eastern Mediterranean Counterterrorism and Maritime Security Partnership Act; Analysis of Threats Posed by Foreign Adversary Access to Controlled Items Within the US; ARMOR Act; Assessment and Report of Foreign Adversary Influence over Strategic Maritime Chokepoints; Assessment of Antisemitism in the Service Academies; Assessment of DOD Display Chain Supply Chain Vulnerabilities; Assessment of Foreign Adversary-Controlled Digital Platforms; Assessment of Military Medical Supply Chains; Assessment of Resilient Missile Defense Sensing Architectures; Assessment of Russian Involvement in Narcotics and Narcotics Trafficking; Audit and Mitigation of Certain Cellular Modules; Audit of CCP-Linked Participation in DOD Contracts and Supply Chains; Baltic Region Security Concerns; Biological Intellectual Property Protection Act; Biotech Investment National Security Act; Briefing on Supply Chain Exposure; Briefing on the Pilot Program to Analyze and Monitor Certain Supply Chains; Bunker Buster Act; Certification Requirement for Motor Carriers Transporting DOD Freight; Certification That No Contractor of DOD Participates in BDS Movement; Chinese Cellular Modules; Chinese Commercial Space Capabilities; Chinese Robotics Capabilities and Strategy; Chinese Supply Chain Monopoly Identification and Diversification; Civilian Cybersecurity Reserve Corps Pilot Program; Clarification of Authority to Counter UAS for Members of the National Guard; Classification of Pass-Through Funding Within Defense Budget Materials; CLEAR Path Act; Codification of EOs Relating to American Airspace Sovereignty and Drone Dominance; Commercial Software for Contested Logistics; Countering Adversarial Gray Zone Campaigns; Countering Biotechnology Threats from Foreign Adversaries; Countering Cartel Hydrocarbon Smuggling; Countering Iranian Threat Networks in the Eastern Mediterranean; Criminal Penalties for Providing Material Support to a Covered Foreign Country; Critical Minerals Traceability Pilot Program; Cyber Incident Reporting Requirements for Operationally Critical Contractors; Deter PRC Aggression Against Taiwan Act; Determination on Eligibility for Cyber Pilot Program; DETERRENCE Act; DETERRENT Act; Development, Test, Evaluation, Demonstration, and Transition to Production of Alternative Low-Cost Weapon Systems; Dialogue and Measures with Respect to Moldova; DIB and Acquisition Reform; Disclosure of Foreign Funding for Elementary and Secondary Schools; DOD Economic Defense Unit; DOD Grant Program to Improve Cybersecurity Resilience of Department-Owned Joint-Use Airports; Domestic and Covered Allied or Partner Country Critical Transportation Manufacturing Assessment; Domestic Production of Short-Wave Infrared Quantum Dot Materials; Electromagnetic Spectrum Operations Review; Elimination of Use of Certain Payment Processing Equipment, Systems, or Services; End the Cyprus Embargo Act; Ensuring Mature-node Semiconductor Availability; Establishment of Army Information Operations Center of Excellence; Establishment of China Watcher Program; Establishment of DIU Office in Israel; Establishment of Eastern Flank NATO Regional SOC and CSIRT Program; Establishment of Strategic Airports Cybersecurity Infrastructure Program; Establishment of US-Israel AI Center; Establishment of US-Ukraine Critical Minerals Investment Screening Mechanism; Evaluation of Standards for EMP Protection; Exceptions for Notifications to the US Government Relating to Specified Foreign Entities; Expanding the Defense Industrial Base Sales Act; Expansion of Permissible Uses of Ukraine Support Fund; Extension and Modification of Indo-Pacific Maritime Security Initiative; Extension and Modification of Report on Military and Security Developments Involving the PRC; Extension of Limitation on Availability of Funds for the Iraqi Security Forces; Extension of Report on IRGC-Affiliated Operatives Abroad; FASC Exclusion Orders for Chinese Military Company Designees; Feasibility of Permanent Basing an F-35 Squadron in Poland; Feasibility Study on Combatant Command Critical Minerals Management; Feasibility Study on Tactical Information Operations Command Authority; GAO Report on AI Integration Across Defense Operations; Government-Wide Critical Mineral Procurement and Resale Authorities Feasibility Study; GPS Modernization; GUARD Act; Guard the Skies Act; Hardware and Firmware Assurance Pilot Program; IMF Reform; Increased Maximum Production Capacity Plans for Key Munitions and Weapons Systems; Indo-Pacific Trilateral Production Pilot Program; Integrated Air and Missile Defense Architecture; Integration of Demand for FMS into Industrial Base Planning; Internal Base Hardening Assessments and Logistics-Node Threat Mitigation; Joint DOD-DHS Security Pilot Program on Prevention of Terrorist Threats Involving Motor Vehicles; Joint US-Taiwan Research, Development, Test, and Evaluation Program; Limitation on Provision of Funds to Elementary and Secondary Schools Hosting Confucius Institutes and Classrooms; Long Range Anti-Ship Missile Surface and Ground Launch; Maritime Security Measures; Medical Supply Chain Risk Identification and Transparency Enhancement; Military Treatment Facility Readiness, Network Reliance, and Cyber Resilience; Modification of Report on Military and Security Developments Involving Russia; Modification of Report on the Military Power of Iran; Modification to Disclosure Requirements for US-Based Foreign Media Outlets; Modifications to Congressional Review of Sanctions with Respect to Russia; Modifications to Public Reporting of Chinese Military Companies Operating in the US; Modifications to Strategy to Eliminate Sourcing of Computer Displays from Certain Nations; Modifications to the Port Security Grant Program; Moldovas Airspace Awareness and Defense Capabilities; MTS Cyber Act; Multiyear Procurement Authorities; National Security Commission on Robotics; NSA Support for DIB and Critical Infrastructure Cybersecurity Operations; Oversight of Military-to-Military Exchanges and Contacts Between the US and Russia; PAID OFF Act; Participation of Ukrainian Students in US Service Academies; Phased Inventory Benchmarks for Combat Coded Fighter Aircraft; Photovoltaic Modules from Foreign Entities of Concern; PILLAR Act; Pilot Program for Adaptive Electronic Warfare-Resilient and Quantum-Secure Autonomy Small UAS Architecture Testing; Pilot Program on DOD Partnerships with IHE Recognized in the NCAE-C Program for Cyber Research; Pilot Program on National Security Risk Identification and Review for Adversarial Capital; Pilot Program on Semiconductor Antitampering and Authenticity Validation; Pilot Program to Improve Participation by Small Business Concerns in Certain DOD Contracts; Plan on Remediation of Certain Equipment and Computational Facilities Owned or Controlled by a Foreign Adversary; Plan Required for Full Participation by Taiwan in the RIMPAC; Plan to Counter PRC Influence and Activities in the FAS; Potential Designation of Information as a Domain of Warfare; PRC Militarization and Surveillance Activities; Procurement of Amoxicillin; Prohibition Against US Recognition of Russia's Claim of Sovereignty over Any Portion of Ukraine; Prohibition on DOD Procurement from, and Servicemember Data Collection by, Companies Storing Data in a Covered Foreign Country; Prohibition on Operation or Procurement of Foreign-Made UAS; Prohibition on Procurement and Operation of Covered Robotic Systems; Prohibition on Procurement by DOD and IC of Chinese-Made Synthetic Datasets for Training AI Models; Prohibition on Transfers to the Badr Organization; Prohibition on TSP Investments; Prohibition on Use of Funds for Ukraine Security Assistance; Protecting US Farmland and Sensitive Sites from Foreign Adversaries Act; Protection of Supply Chain of Certain Drugs; Rail Infrastructure Cybersecurity Enhancement Program; Real-Time and AI-Enabled Property Records; Report and Conditions on Security Assistance to Oman; Report on Accelerating Military Posture Within Area of Responsibility of US INDOPACOM; Report on Counterintelligence Risks Associated with Real Property Transactions Near Military Installations; Report on Dependency on China for Processing Materials for DOD Supply Chains; Report on Forced Conscription of Kidnapped Ukrainian Children into Russian Armed Forces; Report on Foreign-Linked Funding of Legal and Administrative Actions Targeting US and Allied Personnel; Report on Global Automobile Theft Rings; Report on Instances of Antisemitism; Report on Involvement of Certain Foreign Actors in Antisemitic Activity in the US; Report on Military Power and Illicit Activities of Certain Drug Cartels; Report on Modernization of the Aegis Ashore Missile Defense Site at Devesselu, Romania; Report on Moldova Airspace Defense Requirements and Options; Report on PRC Space Capabilities; Report on Production of 155MM Artillery Ammunition; Report on Protection of US Defense Technology; Report on Russias Targeting of Religious Infrastructure in Ukraine; Report on Russian Active Measures in NATO Territory; Report on Russian Efforts in Sudan; Report on Russian Influence in Libya; Report on Russian Influence; Report on Russian Military Presence in Syria; Report on Security Risks Posed by Turkeys Occupation of Cyprus; Report on Taiwan Capabilities and Intelligence Support; Report on the Feasibility of Requiring Bills of Materials for Defense Acquisition; Report on the National Security Implications of Applying Nondiscriminatory Treatment to the PRC; Report on the PRC and Turkey Military and Intelligence Cooperation; Report on Turkey Aiding Hamas or Its Affiliates; Report to Congress on Energy in Moldova; Reporting on Russias Military Power and Capabilities; Reports on Cyber Operational Readiness Assessment Program; Re-Purposing Aircraft from the 309th AMARG; Requirement for Guidance and Prohibition on Use of AI of Certain AI Companies; Requirement for Memoranda of Agreement Regarding Vulnerability Disclosure and Prohibition on Procurement from IT Providers Who Can Share Cyber Vulnerabilities with Countries of Concern; Requirements Related to Certain Sanctions on Russia or Belarus; Restriction on Providing Federal Funds to Certain Entities for Public Works Projects; Restrictions on US Support for Economic Activities Involving Persons Who Benefitted from or Supported the Assad Regime; Review of Intelligence Vulnerabilities of Internet Connected Video Surveillance Equipment on Military Installations; Revocation of Security Clearances for Certain Persons; Safeguarding DOD-Funded Research; Securing Critical US Infrastructure and Mineral Supply Chains; Securing DOD Supply Chains; Securing Innovation and Research from Adversaries Act; Seizure and Forfeiture of Assets of Russian Kleptocrats; Semiconductor Controls Adjusted to Limit Exports Act; Semiconductor Supply Chain Security and Diversification Act; Sense of Congress on Commitment to the AUKUS Partnership; Sense of Congress on Domestic Production of Artillery Projectiles; Sense of Congress on International Defense Exhibitions; Sense of Congress on Nuclear Cooperation Agreements with Saudi Arabia; Sense of Congress on the Gaza Health Ministry; Sense of Congress on the Permanent and Rotational Presence of US Forces in Romania; Sense of Congress Regarding Kosovo Integration into NATO; Sense of Congress Regarding NATO's Kosovo Force; Sense of Congress with Respect to Execution of Warrants of the ICC; Space-Based Missile Defense Strategy; Standards for AI Systems; Strategic Partnership on Defense Industrial Priorities Between the US and Taiwan; Strategy for Establishing a Two-Way Transfer Mechanism for US-Ukraine UAS Expertise; Strategy for the Adoption and Integration of AI; Strategy to Defend Against Risks Posed by the Use of AI; Strategy to Restore Stability to the Western Balkans; Strengthening Continuity of the Economy Planning; Study and Report on International Security Measures on the Border Between Gaza and Egypt; Study, Strategy, and Report on DOD Reliance on Transportation Systems Incorporating Chinese-Origin Components; Taiwan-Five Eyes Cyber Defense Cooperation Initiative; Training for Ukraines Military and National Security Forces; Transatlantic Growth Enterprise Act; Tren de Aragua Border Security Threat Assessment Act; Ukraine Drone Production and Strategy; Ukrainian Military Instructors at Senior Professional Military Education Institutions; Updated Middle East IAMD Strategy; Updates to Certain Asset Lists of the DOD; Upholding the Dayton Peace Agreement Through Sanctions Act; US Counter-Robotics Strategy; US Cybersecurity Capabilities and Strategy; US Drone and Missile Defense Capabilities; US Force Posture in Korea and Europe, US Information Operations Capabilities and Strategy; US International Legal Operations Strategy; US Military Posture in Europe; US-Abraham Accords Defense Cooperation Initiative; US-Cyprus Security Cooperation; USDT Report on Financial Institutions That Support Terrorist Activity; US-European Nuclear Energy Cooperation Act; US-Greece Security Cooperation Reporting Act; US-Israel Cooperation on Space Matters; US-Israel Cooperative Research and Development; US-Israel Defense Technology Cooperation Initiative; US-Israel Security Cooperation; US-Taiwan Security Cooperation; US-Ukraine Drone Working Groups; US-Ukraine EOD Partnership; US-Ukraine Military Trauma Education, Training, Research, and Medical Readiness Partnership; and US-Ukraine Security Cooperation). S. 4784, National Defense Authorization Act for Fiscal Year 2027, (issues related toAbraham Accords Defense Cooperation Initiative; AI Functional Bill of Materials; Analysis of Threats Posed by Foreign Adversary Access to Controlled Items Within the US; Assessment of Taiwans LNG Supply Chains; Assistance to LAF for Countering Hezbollah and Other Terrorist Groups; Audit and Mitigation of Covered Cellular Modules in the DOD Systems and Infrastructure; Briefing on Military and Intelligence Presence of Cuba in the Western Hemisphere; Chinese Cellular Modules; Codification of DOD Research Security Program; Countering Cartel Hydrocarbon Smuggling; Cybersecurity Training for Veterans and Military Spouses; Derived Sourcing Requirements for AI Outputs; DETERRENCE Act; DETERRENT Act; DLA Warstopper Program; DOD Economic Defense Unit; Expansion of Permissible Uses of Ukraine Support Fund; Extension and Modification of Pacific Deterrence Initiative; Extension of Report on Military Power of the PRC; Extension, Modification, and Redesignation of Taiwan Security Cooperation Initiative; Full Accountability for Chinese Military Companies; Inspector General for Foreign Assistance; Internal Base Hardening and Staged Internal Operations; Middle East IAMD Architecture; Modifications to Requirement for Public Reporting of Chinese Military Companies Operating in the US; Multiyear Procurement Authorities; PAID OFF Act; Plan on Remediation of Certain Equipment and Computational Facilities Owned or Controlled by a Foreign Adversary; PRC EMP Capabilities; Report on the Feasibility and Advisability of Establishing a Strategic Partnership on Defense Industrial Priorities between the US and Israel; Reports on Foreign Boycotts of Israel; REVOKE Act; Safeguarding DOD-Funded Research; SECURE Minerals Act; Securing Critical Weapons Systems Supply Chains; Securing US Military Mobility Infrastructure; Securing US Transportation Systems; Stop Foreign Spyware Act; Strategic Subsea Cables Act; Taiwan Energy Security and Embargo Act; Ukraine Drone Production and Strategy; US AI Policy; US Airport Cybersecurity Enhancements; US Critical Infrastructure Resilience Against EMP Weapons; US Cybersecurity Capabilities and Strategy; US Drone and Missile Defense Capabilities; US Healthcare Cybersecurity Enhancements; US Highways Cybersecurity Enhancements; US Indo-Pacific Policy and Strategy; US Maritime Cybersecurity Enhancements; US Rail Infrastructure Cybersecurity Enhancements; US Space Capabilities and Strategy; US-India Security Cooperation; US-Israel Defense Technology Cooperation Initiative; US-Israel Security Cooperation; US-Taiwan Security Cooperation; US-Ukraine Security Cooperation; and US-Ukraine Strategic Defense Innovation Working Group). Issues Related to Air Force Fighter Fleet Recapitalization; Chinas Military-Industrial Complex (CMIC); China-Iran-Russia Security Cooperation and Technology Development; Chinese Military Companies; Counter-Drone Technology Exchanges; Department of Defense Education Policy; Hardening U.S. Military Assets and Bases; Houthi Interdiction Efforts; Implementation and Oversight of the NDAA (FY23 - FY26); Irans Military Strategy and Capabilities; Irans Network of Terror Proxies; Iranian Weapons Proliferation; Operation Epic Fury; PRC Militarization and Surveillance Activities; Preserving Peace and Security in the Eastern Mediterranean; Russias Foreign Policy and Military Strategy; Safeguarding DOD-Funded Research; Securing DOD Supply Chains; U.S. Arms Sales and Procurement Strategies; U.S. CENTCOM Capabilities and Strategy; U.S. Counter-Robotics Strategy; U.S. Critical Mineral Policy and Diplomacy; U.S. DOD Post-Quantum Cryptography; U.S. Drone and Missile Defense Capabilities; U.S. F-35 Program; U.S. Indo-Pacific Strategy and Relations; U.S. Information Operations Capabilities and Strategy; U.S. International Legal Operations Strategy; U.S. Maritime Manufacturing Capacity; U.S. Military Posture in Europe; U.S. Military Posture in the Middle East; U.S. Nigeria Security Cooperation; U.S. Nuclear Deterrence Policy; U.S. Policy on Irans Ballistic Missile and Nuclear Programs; U.S. Policy on Irans Support for Terrorism; U.S. Policy on Russias War in Ukraine; U.S.-Iraq Security Cooperation; U.S.-Israel Security Cooperation; U.S.-Lebanon Security Cooperation; U.S.-NATO Security Cooperation; U.S.-Taiwan Security Cooperation; U.S.-Turkey Security Cooperation; U.S.-Ukraine Security Cooperation; and Ukraine Drone Production and Strategy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"H.R. 2658, Free Iraq from Iran Act, all provisions. H.R. 3307, Eastern Mediterranean Gateway Act, all provisions. H.R. 3563, Taiwan PLUS Act, all provisions. H.R. 36, MEGOBARI Act, all provisions. H.R. 4531, BANNED in Latin America Act, all provisions. H.R. 6230, Tehran Incitement to Violence Act, all provisions. H.R. 6469, Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act, all provisions. H.R. 7380, Internet Reach and Access Now (IRAN) Act, all provisions. H.R. 7567, Farm, Food, and National Security Act of 2026 (issues related to Binational Agricultural Research and Development; CFIUS Consideration of Certain Agricultural Land Transactions; and Rural Water and Wastewater Circuit Rider Program). H.R. 7622, Iran Human Rights, Internet Freedom, and Accountability Act of 2026, all provisions. H.R. 7668, Countering Chinas Control of the Caucasus Act, all provisions. H.R. 8433, Countering Russias War on Faith Act, all provisions. H.R. 8595, National Security, Department of State, and Related Programs Appropriations Act, 2027, (issues related to International Narcotics and Law Enforcement; Democracy Programs in Latin America; and Assistance to South Africa). H.R. 8693, Deter PRC Aggression Against Taiwan Act, all provisions. H.R. 8700, Protecting U.S. Farmland and Sensitive Sites from Foreign Adversaries Act, all provisions. H.R. 8718, Countering Russias Forced Recruitment and Kidnapping in Africa Act, all provisions. H.R. 9020, No U.S. Funding for UNIFIL Act, all provisions. H.R. 9087, To direct the Secretary of State to take actions with respect to certain foreign affairs matters, (issues related to Baltic Regional Security; Gaza Health Ministry; Certification Requirement for Major Arms Sales to Turkey; IGO Anti-Boycott Act; and BANNED in Latin America Act). H.R. 9147, Abraham Accords Expansion Act of 2026, all provisions. H.R. 9450, Countering Russian Trafficking Act, all provisions. H.Res. 1379, Condemning Lebanese Hezbollahs repeated violations of ceasefire agreements and calling for the Lebanese Government to ensure Lebanese Hezbollah immediately ceases all attacks and disarms, in accordance with the ceasefire, all provisions. S. 1824, Taiwan PLUS Act, all provisions. S. 3360, Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act, all provisions. S. 3496, United States Legal Gold and Mining Partnership Act, all provisions. S. 3900, Iran Human Rights, Internet Freedom, and Accountability Act of 2026, all provisions. S. 4192, Property Location Oversight and Transparency (PLOT) Act of 2026, all provisions. S. 4296, IGO Anti-Boycott Act, all provisions. S. 4379, Countering Russias War on Faith Act, all provisions. S. 4392, Energy Security Pacts Act, all provisions. S. 4600, South China Sea Strategy Act of 2026, all provisions. S. 4665, BANNED in Latin America Act, all provisions. S. 4853, United States-Israel Agriculture Cooperation Improvement and Expansion Act, all provisions. H.R. 8800, National Defense Authorization Act for Fiscal Year 2027, (issues related to Abraham Accords Central Asia Expansion Act; Abaraham Accords Authorities Expansion; Accountability for Terrorist Perpetrators of October 7th Act; Arms Delivery Queue Report; Arms Sales and Weapons System Transfers to NATO countries; Authorization of Activities to Counter Russia; BANNED in Latin America Act; Business in the Balkans; Captagon, Fentanyl, and International Narcotics Production and Trafficking; Certification Requirement for Major Arms Sales to Turkey; Closing Loopholes in Russia Sanctions; Countering Russias War on Faith Act; Deployment of a Financial Attache to the US Embassy in Jerusalem; Deterring Adversary Ill-Gotten Gains Act; AI OVERWATCH Act; American Space Leadership for the 21st Century Act; BIS License Administration Enhancement Act; BIS STRENGTH Act; Block the Use of Transatlantic Technology in Iranian Made Drones Act; China AI Power Report Act; Chip Security Act; Countering Chinas Control of the Caucasus; Countering Russias Forced Recruitment and Kidnapping in Africa Act; Deterring American AI Model Theft Act; Dismantle Foreign Scam Syndicates Act; Developing Overseas Mineral Investments and New Allied Networks for Critical Energies (DOMINANCE) Act; Decreasing Russia Oil Profits (DROP) Act; ECRA Penalty Increase Act; ECRA Statute of Limitations Extension; Enhanced Iran Sanctions Act; Export Control Enforcement and Enhancement Act; Export Controls Enforcement Act; Foreign Adversary AI Risk Assessment and Diplomacy Act; Feasibility Review of Emerging Equipment for Digital Open Media (FREEDOM) Act; Full AI Stack Export Promotion Act; Interagency Coordination in Export Controls Act; Interagency Strategy to Disrupt and Dismantle Narcotics Production and Trafficking and Affiliated Networks Linked to the Regime of Bashar al-Assad in Syria; ITAR Licensing Reform Act; Kleptocracy Asset Recovery Rewards Program Act; Limitation on Contributions to the UN; Limitation on Transfer of Weapons to Turkey; Limitation Regarding Certain Export Controls; Multilateral Alignment of Technology Controls on Hardware (MATCH) Act; MEGOBARI Act; No US Funding for UNIFIL Act; No Official Palestine Entry (NOPE) Act; Participation of Russia in the G7; Preventing the Escalation of Armed Conflict in Europe (PEACE) Act; Peace Through Strength Act; Polisario Front Terrorist Designation Act; Preventing Rogue Equipment for Synthetic Substances (PRESS) Act; Prohibition on Delay of Arms Sales to Taiwan; Remote Access Security Act; REPO Implementation Act; Report on Allied Information Sharing to Counter Foreign Malign Influence; Report on Backlog of FMS to Taiwan; Russia-North Korea Cooperation Sanctions Act; Sanctions List Harmonization Act; Strategic Hybrid Activities Defense and Operations for the West (SHADOW) Act; STOP HATE Act; Stop Stealing Our Chips Act; Strategic Dialogue to Return Democratic Rule to Belarus; Strategic Subsea Cables Act; Streamlining Foreign Military Sales Act; Semiconductor Technology Resilience, Integrity, and Defense Enhancement (STRIDE) Act; Taiwan Allies Fund Act; Taiwan Energy Security and Anti-Embargo Act; Taiwan PLUS Act; US Arms Sales and Procurement Strategies; US Iran Sanctions Policy; US Support for the Iranian People; War Reserve Stockpiles for Allies; and XPCC Sanctions Act). S. 4784, National Defense Authorization Act for Fiscal Year 2027, (issues related to BANNED in Latin America Act; BIS License Administration Enhancement Act; BIS STRENGTH Act; China AI Power Report Act; Chip Security Act; Countering Chinas Control of the Caucuses Act; Critical Undersea Infrastructure Resilience Initiative Act; Deterring American AI Model Theft Act; Eastern Mediterranean Gateway Act; ECRA Statute of Limitations Extension Act; Eliminate PRC Organized Crime Act; FREEDOM Act; Imposition of Sanctions with Respect to Trade in Russian Origin Petroleum Products; Iran Human Rights, Internet Freedom, and Accountability Act; MATCH Act; MEGOBARI Act; No Hezbollah In Our Hemisphere Act; PORCUPINE Act; Religious Infrastructure in Ukraine; Remote Access Security Act; REPO Implementation Act; Sense of Congress on Illegal Abduction of Ukrainian Children by Russia; SHADOW Fleet Sanctions Act; Statement of Policy on Repeal of Sunset of Iran Sanctions Act of 1996; US Iran Sanctions Policy; US Legal Gold and Mining Partnership Act; US Russia Oil Waivers and Sanctions Policy; US Sanctions Authorities, Implementation, Enforcement, Resourcing, and Policy; US South Africa Bilateral Relations Review Act; and War Reserve Stockpiles for Allies). Issues related to Abraham Accords Authorities; AGOA Reauthorization; Chinas Foreign Policy and Military Strategy; Chinese and Russian Activities in Africa; Chinese Investments in the Middle East; Chinese, Iranian, and Russian Activities in Latin America; Congressional Oversight of U.S. Arms Sales; Congressional Oversight of U.S. Foreign Assistance; Implementation and Oversight of Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Implementation and Oversight of Consolidated Appropriations Act, 2026; Implementation and Oversight of Continuing Appropriations, Agriculture, Legislative Branch, Military Construction, and Veterans Affairs, and Extension Act, 2026; Implementation and Oversight of the Iran Nuclear Agreement Review Act; Implementation and Oversight of the National Security Act of 2024; Israel-Syria Relations; Normalization in the Middle East; Protecting International Religious Freedom; Qatars, South Africas, and Turkeys Support of Terrorism; Russias Mass Abduction of Ukrainian Children; Strengthening the National Endowment for Democracy; Support for U.S. Allies at International Organizations; Syria-Turkey Relations; U.S. Contributions to and Oversight of International Organizations; U.S. Energy Security Policy; U.S. Foreign Affairs-Related Appropriations; U.S. Foreign Aid Policy and Reform; U.S. International Development Finance Corporation; U.S. Policy on Chinas Human Rights Abuses and Repression; U.S. Policy on Irans Human Rights Abuses and Censorship; U.S. Support for the Iranian People; U.S. Victims of Terrorism; U.S. Western Balkans Strategy; U.S.-Cuba Policy and Relations; U.S.-Honduras Policy and Relations; U.S.-Iran MOU and Negotiations; U.S.-Iraq Relations; U.S.-Latin America Foreign Policy and Strategy; U.S.-Mexico Policy and Relations; U.S.-Nicaragua Policy and Relations; U.S.-Qatar Policy and Relations; U.S.-South Africa Policy and Relations; U.S.-South Korea Policy and Relations; U.S.-Turkey Policy and Relations; U.S.-Venezuela Energy Policy; U.S.-Venezuela Policy and Relations (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145330,"prefix":"mr","prefix_display":"MR.","first_name":"NICHOLAS","nickname":"NICK","middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"H.R. 1736, Generative AI Terrorism Risk Assessment Act, all provisions. H.R. 2158, Countering Transnational Repression Act of 2025, all provisions. H.R. 2212, DHS Intelligence Rotational Assignment Program and Law Enforcement Support Act, all provisions. H.R. 3463, Comprehensive Operations for Unmanned-System Neutralization and Threat Elimination Response (COUNTER) Act, all provisions. H.R. 6105, Restricting Ex-Vetted Officials from Knowledge Exploitation (REVOKE) Act, all provisions. H.R. 6106, Conflict-free Leaving Employment and Activity Restrictions (CLEAR) Path Act, all provisions. H.R. 6107, Preventing Adversary Influence, Disinformation, and Obscured Foreign Financing (PAID OFF) Act of 2025, all provisions. H.R. 8022, DETECT Nitazenes Act of 2026, all provisions. H.R. 881, DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act, all provisions. S. 2132, CLEAR Path Act, all provisions. S. 3050, Preventing Adversary Influence, Disinformation, and Obscured Foreign Financing (PAID OFF) Act of 2025, all provisions. S. 3181, REVOKE Act, all provisions. Issues related to Foreign Threats to U.S. Homeland (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"H.R. 4142, No Adversarial AI Act, all provisions. H.R. 6309, Cyber Deterrence and Response Act of 2025, all provisions. H.R. 7037, Developing Overseas Mineral Investments and New Allied Networks for Critical Energies (DOMINANCE) Act, all provisions. H.R. 7625, Marine Transportation System Cybersecurity Budget and Evaluation Report (MTS CYBER) Act of 2026, all provisions. H.R. 7924, Trucking Security and CCP Disclosure Act of 2026, all provisions. H.R. 8516, American Leadership in AI Act, all provisions. H.R. 8558, Defending American Research Act, all provisions. H.R. 8730, Connected Vehicle Security Act of 2026, all provisions. H.R. 9102, Biotech Investment National Security Act (BINSA), all provisions. H.R. 9129, Guarding the U.S. Against Adversarial Robotics Dominance (GUARD) Act of 2026, all provisions. H.R. 9227, Magnets Value Chain Support Act of 2026, all provisions. H.R. 9592, American Space Leadership in the 21st Century Act, all provisions. S. 4429, Connected Vehicle Security Act of 2026, all provisions. S. 4525, Securing Innovation and Research from Adversaries Act, all provisions. S. 4565, Strengthening Cyber Resilience Against State-Sponsored Threats Act, all provisions. S. 4570, U.S. Tech Path Act, all provisions. Issues Related to Chinese Biotech Industry and Dual-Use Threats; Chinese Cellular Modules; Chinese EV Manufacturing; Chinese Robotics Capabilities and Strategy; Chinese Unmanned Aerial Systems; Chinese, Iranian, and Russian Cyber Operations; Chinese-Made Battery Storage Systems; CISA Resourcing; Cyber-Informed Engineering; Cybersecurity Capabilities of U.S. Allies; Development of Internet Access Technologies; Information Technology Devices from Foreign Adversary-Controlled Companies; Light Detection and Ranging Sensor Technology; National Guard Role in Cyber Incident Response; Securing Critical U.S. Infrastructure and Mineral Supply Chains; Securing U.S. Defense Technology; Securing U.S. Military Mobility Infrastructure; Securing U.S. Transportation Systems; U.S. Adversarial Use of AI and Quantum Technology; U.S. AI Chip Security; U.S. Airport Cybersecurity Enhancements; U.S. Artificial Intelligence Policy; U.S. Cybersecurity Capabilities and Strategy; U.S. Data Security Capabilities and Strategy; U.S. Drone Production and Market Security; U.S. Emerging Technology Capabilities, Development, and Strategy; U.S. Fusion Energy Development; U.S. Healthcare Cybersecurity Enhancements; U.S. Highways Cybersecurity Enhancements; U.S. Maritime Cybersecurity Enhancements; U.S. Nuclear Energy Capabilities; U.S. Quantum Technology Capabilities; U.S. Rail Infrastructure Cybersecurity Enhancements; U.S. Space Capabilities and Strategy (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1048, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, all provisions. H.R. 8559, No Branch Campuses in Hostile Countries Act, all provisions. H.R. 8901, Securing Innovation and Research from Adversaries Act, all provisions. S. 1296, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, all provisions. S. 4423, Defending American Research Act, all provisions. S. 4424, No Branch Campuses in Hostile Countries Act, all provisions. Issues related to Foreign Gift Compliance Transparency; Foreign Influence in Nonprofit Sector; Foreign Influence in U.S. Higher and Elementary Education; and Securing American Funding and Expertise from Adversarial Research Exploitation (no bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71983,"prefix":null,"prefix_display":null,"first_name":"TYLER","nickname":null,"middle_name":null,"last_name":"STAPLETON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152507,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRIA","nickname":null,"middle_name":null,"last_name":"PAOLOZZI MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152508,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"VAYNSHTEYN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 6988, Trade Transparency Unit Strategy Act, all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146703,"prefix":"mr","prefix_display":"MR.","first_name":"CONNOR","nickname":null,"middle_name":"RUSSELL","last_name":"PFEIFFER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141587,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW REID","nickname":null,"middle_name":"WITTE","last_name":"ZWEIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151813,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"JUTCOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7283a169-a2bb-4340-acbc-dcf272a16fc0/","filing_uuid":"7283a169-a2bb-4340-acbc-dcf272a16fc0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7283a169-a2bb-4340-acbc-dcf272a16fc0/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig Monson","dt_posted":"2026-07-20T14:59:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":175642,"url":"https://lda.gov/api/v1/clients/175642/","client_id":1006245,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","general_description":"A coalition of organizations working on market-based solutions to drug pricing.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-07-12"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/S. 1533 - The Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/956076c6-86a3-42ed-bf18-8375d3295b7b/","filing_uuid":"956076c6-86a3-42ed-bf18-8375d3295b7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/956076c6-86a3-42ed-bf18-8375d3295b7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"7360000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-07-20T15:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S.___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.___: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S.___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Presidents Budget Fiscal Year 2027 Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9661: Expedited Access to Biosimilars Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 6089: Biomanufacturing Excellence Act of 2025 H.R. 9102: Biotech Investment National Security Act of 2026 (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3/","filing_uuid":"d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Anne O. Riser","dt_posted":"2026-07-20T17:19:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 MASSACHUSETTS AVENUE, NW","registrant_address_2":"SUITE 310","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7554,"url":"https://lda.gov/api/v1/registrants/7554/","house_registrant_id":31585,"name":"BUSINESS SOFTWARE ALLIANCE","description":null,"address_1":"200 MASSACHUSETTS AVENUE, NW","address_2":"SUITE 310","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE RISER","contact_telephone":"+1 202-530-5148","dt_updated":"2026-07-16T15:45:10.679271-04:00"},"client":{"id":110754,"url":"https://lda.gov/api/v1/clients/110754/","client_id":12,"name":"BUSINESS SOFTWARE ALLIANCE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-30"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"National Defense Authorization Act generally, and including the House FY26 NDAA, S. 2296 - the Senate FY26 NDAA, S. 4784 - National Defense Authorization Act for Fiscal Year 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Domestic law enforcement access to digital evidence generally, S. 3663/H.R. 6048 NDO Fairness Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Issues pertaining to workforce development and retraining issues, S. 2976 - Halting International Relocation of Employment (HIRE) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"Issues related to intelligence community surveillance of electronic communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues pertaining to market access for software products and services in international markets including, but not limited to, provisions related to intellectual property protection and market access for software products and services, S. 3399 - Digital Trade Promotion Act of 2025 Issues pertaining to international trade agreements including, but not limited to, provisions relating to IP protection and enforcement, electronic commerce, services and government procurement, including H.R. 2683 - Remote Access Security Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Issues related to modernization of government technology generally, including FedRAMP Issues related to quantum technology, including S. 1344/H.R. 3220 - Quantum Sandbox for Near-Term Applications Act of 2025, S. 1746 - Quantum LEAP Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 2558 - The National Quantum Cybersecurity Migration Strategy Act of 2025, H.R. 4942 - Quantum Encryption Readiness and Resilience Act, S.3597 National Quantum Initiative Reauthorization Act of 2026 Issues pertaining to Cybersecurity generally, and including H.R. 1000 - Cyber PIVOTT Act, S. 1337 - Cybersecurity Information Sharing Extension Act Issues pertaining to the development of Artificial Intelligence generally, and specifically, S. 146 - TAKE IT DOWN Act, H.R. 633 - TAKE IT DOWN Act, H.R. 2385 - CREATE AI Act, S. 1792 - AI Whistleblower Protection Act, S. 2081 - RISE Act of 2025, H.R. 4142 - Adversarial AI Act of 2025, S. 2750 - SANDBOX Act, S. 3150 - GAIN AI Act, H.R. 6875 - Overwatch AI Act, H.R.8516 - American Leadership in AI Act, H.R. 9442 - Artificial Intelligence Data Center Moratorium Act Issues pertaining to government procurement of software generally, and including the FoRGED Act, the Safeguarding American Innovation Act, H.R. 2417 - Strengthening Agency Management and Oversight of Software Assets Act, S. 1362/H.R. 2765 - SAFE Supply Chains Act, H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery (SPEED) Act, H.R. 3961 - Safeguarding American Innovation Act, H.R. 7604 Contracting America First Act, H.R. 8189 - American Security Robotics Act, S. 4570 - U.S. Tech PATH Act Comprehensive federal privacy legislation, generally and including S. 836 - Children and Teens Online Privacy Protection Act, S. 1748 - Kids Online Safety Act, H.R.8413 - Secure Data Act Issues pertaining to content moderation and Section 230 generally","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets, and including S. 1553 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":207,"name":"U.S. Copyright Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30/","filing_uuid":"b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b6ff2b38-c35d-44b1-ab07-83a8b3bc4a30/print/","filing_document_content_type":"text/html","income":null,"expenses":"3282990.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-07-20T17:50:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW, 9th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services S.4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ba5f1486-5cea-4409-8ad4-729a92dbd5a8/","filing_uuid":"ba5f1486-5cea-4409-8ad4-729a92dbd5a8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/ba5f1486-5cea-4409-8ad4-729a92dbd5a8/print/","filing_document_content_type":"text/html","income":null,"expenses":"420000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tavarski Hughes","dt_posted":"2026-10-19T13:23:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"240 Madison Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"MEMPHIS","registrant_state":"TN","registrant_zip":"38103","registrant":{"id":6440,"url":"https://lda.gov/api/v1/registrants/6440/","house_registrant_id":33435,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","description":null,"address_1":"240 Madison Avenue","address_2":null,"address_3":null,"address_4":null,"city":"MEMPHIS","state":"TN","state_display":"Tennessee","zip":"38103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAVARSKI HUGHES","contact_telephone":"+1 901-417-2486","dt_updated":"2026-07-18T18:34:35.847553-04:00"},"client":{"id":108763,"url":"https://lda.gov/api/v1/clients/108763/","client_id":12,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Hospital Billing/Consolidation; Maternal Health; Employer Provided Health Coverage; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Suprise Billing; Artificial Intelligence S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes. H.R. 8684 - Transparency in Billing Act of 2026 To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 9393 - Lower Costs, More Transparency Act of 2026 To promote price transparency in the health care sector S. 2301 - Improving Care in Rural Camerica Reauthorization Act of 2025 To reauthorize certain programs regarding rural health care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform; Program Fraud Waste and Abuse; Durable Medical Equipment S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington H.R. 9392 - Medicare Advantage Cost Transparency Act To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data. H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 To amend Title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. H.R. 8871 - DME Scammer Prevention Act of 2026 To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies. S. 3762 - Prior Authorization Relief Act To amend part C of the title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d38c5fb4-f4a5-4783-837e-0c38685ea8a7/","filing_uuid":"d38c5fb4-f4a5-4783-837e-0c38685ea8a7","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d38c5fb4-f4a5-4783-837e-0c38685ea8a7/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig Monson","dt_posted":"2026-10-20T08:59:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":175642,"url":"https://lda.gov/api/v1/clients/175642/","client_id":1006245,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","general_description":"A coalition of organizations working on market-based solutions to drug pricing.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-07-12"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/S. 1533 - The Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/40da8d86-4e7b-425f-8f96-82a2b874d369/","filing_uuid":"40da8d86-4e7b-425f-8f96-82a2b874d369","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/40da8d86-4e7b-425f-8f96-82a2b874d369/print/","filing_document_content_type":"text/html","income":null,"expenses":"3203049.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jonathan Heafitz","dt_posted":"2026-10-20T10:28:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"505 9th Street NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31348,"url":"https://lda.gov/api/v1/registrants/31348/","house_registrant_id":34004,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","description":"Issues relating to prescription drug benefits","address_1":"325 7th Street NW, 9th Floor","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN HEAFITZ","contact_telephone":"+1 202-756-5735","dt_updated":"2026-07-22T16:58:34.643878-04:00"},"client":{"id":138221,"url":"https://lda.gov/api/v1/clients/138221/","client_id":12,"name":"PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION","general_description":"no change","client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S.4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9393; Lower Costs, More Transparency Act H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S.2276/ H.R. 3269; Eliminating Thickets to Improve Competition Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":90,"name":"Small Business Administration (SBA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44250,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":"M","last_name":"HEAFITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143598,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"LEBENS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147046,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"THREADGILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149676,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"BUSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153596,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"MARIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7b7372e1-551f-4eac-afa5-105a6670c2fe/","filing_uuid":"7b7372e1-551f-4eac-afa5-105a6670c2fe","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/7b7372e1-551f-4eac-afa5-105a6670c2fe/print/","filing_document_content_type":"text/html","income":null,"expenses":"1530000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-10-20T16:45:00-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #1000","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155671,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"MCCONE","suffix":null,"suffix_display":null},"covered_position":"Rep. Jan Schakowsky, Intern, June 2014-Aug 2014, Rep. Joe Crowley, Intern, Jan 2016-April 2016, Rep. Chuck Schumer, Intern, April 2016-July 2016, Rep. Raja Krishnamoorthi, Sept 2017-May 2018, Rep. Mark Pocan, Scheduler, May 2018-May 2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155671,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"MCCONE","suffix":null,"suffix_display":null},"covered_position":"Rep. Jan Schakowsky, Intern, June 2014-Aug 2014, Rep. Joe Crowley, Intern, Jan 2016-April 2016, Rep. Chuck Schumer, Intern, April 2016-July 2016, Rep. Raja Krishnamoorthi, Sept 2017-May 2018, Rep. Mark Pocan, Scheduler, May 2018-May 2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6509: SAFE Drugs Act of 2025 H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9599: SECURE 340B Act H.R. 9661: Expedited Access to Biosimilars Act 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Peptides/counterfeiting policy issues Controlled substances policy issues Generics/devices policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B Rebate Model Pilot Program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155671,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"MCCONE","suffix":null,"suffix_display":null},"covered_position":"Rep. Jan Schakowsky, Intern, June 2014-Aug 2014, Rep. Joe Crowley, Intern, Jan 2016-April 2016, Rep. Chuck Schumer, Intern, April 2016-July 2016, Rep. Raja Krishnamoorthi, Sept 2017-May 2018, Rep. Mark Pocan, Scheduler, May 2018-May 2020","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and Affordability Act S. 5571: Biosimilars Access and Affordability Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155671,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"MCCONE","suffix":null,"suffix_display":null},"covered_position":"Rep. Jan Schakowsky, Intern, June 2014-Aug 2014, Rep. Joe Crowley, Intern, Jan 2016-April 2016, Rep. Chuck Schumer, Intern, April 2016-July 2016, Rep. Raja Krishnamoorthi, Sept 2017-May 2018, Rep. Mark Pocan, Scheduler, May 2018-May 2020","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 3452: Biological Intellectual Property Protection Act of 2025 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5265: USTRx Act S. 5316: Biotech Investment National Security Act (BINSA) H.R. 4780: USTRx Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155671,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"MCCONE","suffix":null,"suffix_display":null},"covered_position":"Rep. Jan Schakowsky, Intern, June 2014-Aug 2014, Rep. Joe Crowley, Intern, Jan 2016-April 2016, Rep. Chuck Schumer, Intern, April 2016-July 2016, Rep. Raja Krishnamoorthi, Sept 2017-May 2018, Rep. Mark Pocan, Scheduler, May 2018-May 2020","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/afab4741-599f-4aea-ae8f-597ba4797e76/","filing_uuid":"afab4741-599f-4aea-ae8f-597ba4797e76","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/afab4741-599f-4aea-ae8f-597ba4797e76/print/","filing_document_content_type":"text/html","income":null,"expenses":"7040000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-10-20T16:51:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6509: SAFE Drugs Act of 2025 H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9599: SECURE 340B Act H.R. 9661: Expedited Access to Biosimilars Act 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Peptides/counterfeiting policy issues Controlled substances policy issues Generics/devices policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B Rebate Model Pilot Program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and Affordability Act S. 5571: Biosimilars Access and Affordability Act Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 3452: Biological Intellectual Property Protection Act of 2025 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5265: USTRx Act S. 5316: Biotech Investment National Security Act (BINSA) H.R. 4780: USTRx Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}